Logo image of HCWC

HEALTHY CHOICE WELLNESS CORP (HCWC) Stock Fundamental Analysis

USA - NYSEARCA:HCWC - US42227T1051 - Common Stock

0.77 USD
+0.21 (+37.5%)
Last: 9/16/2025, 8:04:01 PM
0.87 USD
+0.1 (+12.99%)
After Hours: 9/16/2025, 8:04:01 PM
Fundamental Rating

2

Taking everything into account, HCWC scores 2 out of 10 in our fundamental rating. HCWC was compared to 40 industry peers in the Consumer Staples Distribution & Retail industry. Both the profitability and financial health of HCWC have multiple concerns. HCWC is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

2

1. Profitability

1.1 Basic Checks

HCWC had negative earnings in the past year.
HCWC had a positive operating cash flow in the past year.
HCWC Yearly Net Income VS EBIT VS OCF VS FCFHCWC Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2021 2022 2023 2024 0 -2M -4M -6M -8M

1.2 Ratios

The Return On Assets of HCWC (-13.25%) is worse than 85.00% of its industry peers.
HCWC's Return On Equity of -212.57% is on the low side compared to the rest of the industry. HCWC is outperformed by 92.50% of its industry peers.
Industry RankSector Rank
ROA -13.25%
ROE -212.57%
ROIC N/A
ROA(3y)-19.39%
ROA(5y)N/A
ROE(3y)-107.09%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
HCWC Yearly ROA, ROE, ROICHCWC Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2021 2022 2023 2024 -50 -100 -150

1.3 Margins

Looking at the Gross Margin, with a value of 39.14%, HCWC belongs to the top of the industry, outperforming 87.50% of the companies in the same industry.
In the last couple of years the Gross Margin of HCWC has grown nicely.
The Profit Margin and Operating Margin are not available for HCWC so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 39.14%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y2.69%
GM growth 5YN/A
HCWC Yearly Profit, Operating, Gross MarginsHCWC Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2021 2022 2023 2024 0 10 -10 20 30

More info and screens

1

2. Health

2.1 Basic Checks

HCWC does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, HCWC has about the same amount of shares outstanding.
Compared to 1 year ago, HCWC has a worse debt to assets ratio.
HCWC Yearly Shares OutstandingHCWC Yearly Shares OutstandingYearly Shares Outstanding 2021 2022 2023 2024 2M 4M 6M 8M
HCWC Yearly Total Debt VS Total AssetsHCWC Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2021 2022 2023 2024 10M 20M 30M

2.2 Solvency

An Altman-Z score of 2.04 indicates that HCWC is not a great score, but indicates only limited risk for bankruptcy at the moment.
HCWC has a worse Altman-Z score (2.04) than 70.00% of its industry peers.
HCWC has a debt to FCF ratio of 41.49. This is a negative value and a sign of low solvency as HCWC would need 41.49 years to pay back of all of its debts.
HCWC's Debt to FCF ratio of 41.49 is on the low side compared to the rest of the industry. HCWC is outperformed by 72.50% of its industry peers.
A Debt/Equity ratio of 4.21 is on the high side and indicates that HCWC has dependencies on debt financing.
HCWC has a Debt to Equity ratio of 4.21. This is amonst the worse of the industry: HCWC underperforms 92.50% of its industry peers.
Industry RankSector Rank
Debt/Equity 4.21
Debt/FCF 41.49
Altman-Z 2.04
ROIC/WACCN/A
WACC8.98%
HCWC Yearly LT Debt VS Equity VS FCFHCWC Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2021 2022 2023 2024 0 5M 10M 15M

2.3 Liquidity

A Current Ratio of 0.82 indicates that HCWC may have some problems paying its short term obligations.
Looking at the Current ratio, with a value of 0.82, HCWC is doing worse than 80.00% of the companies in the same industry.
HCWC has a Quick Ratio of 0.82. This is a bad value and indicates that HCWC is not financially healthy enough and could expect problems in meeting its short term obligations.
Looking at the Quick ratio, with a value of 0.29, HCWC is doing worse than 75.00% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 0.82
Quick Ratio 0.29
HCWC Yearly Current Assets VS Current LiabilitesHCWC Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2021 2022 2023 2024 2M 4M 6M 8M 10M

More info and screens

6

3. Growth

3.1 Past

HCWC shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 52.68%, which is quite impressive.
HCWC shows a strong growth in Revenue. In the last year, the Revenue has grown by 24.57%.
HCWC shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 83.46% yearly.
EPS 1Y (TTM)52.68%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%0.98%
Revenue 1Y (TTM)24.57%
Revenue growth 3Y83.46%
Revenue growth 5YN/A
Sales Q2Q%27.47%

3.2 Future

HCWC is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 32.02% yearly.
Based on estimates for the next years, HCWC will show a quite strong growth in Revenue. The Revenue will grow by 14.78% on average per year.
EPS Next Y37.14%
EPS Next 2Y32.02%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year17.67%
Revenue Next 2Y14.78%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
HCWC Yearly Revenue VS EstimatesHCWC Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2021 2022 2023 2024 2025 2026 20M 40M 60M 80M
HCWC Yearly EPS VS EstimatesHCWC Yearly EPS VS EstimatesYearly EPS VS Estimates 2024 2025 2026 -0.1 -0.2 -0.3

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for HCWC. In the last year negative earnings were reported.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for HCWC. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
HCWC Price Earnings VS Forward Price EarningsHCWC Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20

4.2 Price Multiples

HCWC's Price/Free Cash Flow ratio is a bit more expensive when compared to the industry. HCWC is more expensive than 60.00% of the companies in the same industry.
Industry RankSector Rank
P/FCF 41.43
EV/EBITDA N/A
HCWC Per share dataHCWC EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 2 3 4 5

4.3 Compensation for Growth

A more expensive valuation may be justified as HCWC's earnings are expected to grow with 32.02% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y32.02%
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for HCWC!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

HEALTHY CHOICE WELLNESS CORP

NYSEARCA:HCWC (9/16/2025, 8:04:01 PM)

After market: 0.87 +0.1 (+12.99%)

0.77

+0.21 (+37.5%)

Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupConsumer Staples Distribution & Retail
GICS IndustryConsumer Staples Distribution & Retail
Earnings (Last)08-14 2025-08-14/amc
Earnings (Next)N/A N/A
Inst Owners0.39%
Inst Owner Change228.94%
Ins Owners16.76%
Ins Owner Change0%
Market Cap10.63M
Analysts82.86
Price Target2.04 (164.94%)
Short Float %0.28%
Short Ratio0.18
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)30.67%
Min EPS beat(2)29.97%
Max EPS beat(2)31.37%
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)1.48%
Min Revenue beat(2)-1.58%
Max Revenue beat(2)4.54%
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-25%
EPS NY rev (1m)-4.76%
EPS NY rev (3m)-4.76%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)1.86%
Revenue NY rev (3m)3.33%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.14
P/FCF 41.43
P/OCF 18.92
P/B 5
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-0.47
EYN/A
EPS(NY)-0.09
Fwd EYN/A
FCF(TTM)0.02
FCFY2.41%
OCF(TTM)0.04
OCFY5.29%
SpS5.34
BVpS0.15
TBVpS-0.38
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -13.25%
ROE -212.57%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 39.14%
FCFM 0.35%
ROA(3y)-19.39%
ROA(5y)N/A
ROE(3y)-107.09%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y2.69%
GM growth 5YN/A
F-Score6
Asset Turnover2.16
Health
Industry RankSector Rank
Debt/Equity 4.21
Debt/FCF 41.49
Debt/EBITDA N/A
Cap/Depr 18.56%
Cap/Sales 0.41%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.82
Quick Ratio 0.29
Altman-Z 2.04
F-Score6
WACC8.98%
ROIC/WACCN/A
Cap/Depr(3y)22.38%
Cap/Depr(5y)N/A
Cap/Sales(3y)0.67%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)52.68%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%0.98%
EPS Next Y37.14%
EPS Next 2Y32.02%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)24.57%
Revenue growth 3Y83.46%
Revenue growth 5YN/A
Sales Q2Q%27.47%
Revenue Next Year17.67%
Revenue Next 2Y14.78%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y53.78%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-22.61%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-21.36%
OCF growth 3YN/A
OCF growth 5YN/A